文献速递复苏、休克与脓毒症心脑血管急症

识别对院外心脏骤停后生存的影响及对生物传感器技术的意义

The effect of recognition on survival after out-of-hospital cardiac arrest and implications for biosensor technologies.
PubMed 文献 · Resuscitation · 2023-07-13
一句话结论旁观者目击的院外心脏骤停中,识别贡献了84%的生存获益;若所有未被目击病例均被识别但未干预,预计可多存活912例。

该研究基于不列颠哥伦比亚心脏骤停登记(2019-2020年)的13,655例经急救医疗服务评估的院外心脏骤停病例,排除无早期识别获益者后纳入11,412例(6314例接受急救治疗,5098例未接受)。未目击病例出院生存为191/8879(2.2%),旁观者目击病例为429/2533(17%)。中介分析显示,旁观者目击的总效应中识别占84%(95%CI:72,86)。若所有未目击病例均被旁观者目击,预计增加1198例生存者;若仅被识别而未实施干预,预计增加912例生存者。作者认为,改善识别(如生物传感器技术)可能带来整体生存的实质性改善。

要点

  • 未目击院外心脏骤停出院生存仅191/8879(2.2%),旁观者目击者为429/2533(17%)。
  • 旁观者目击的总生存获益中,识别贡献84%(95%CI:72,86)。
  • 若所有未目击病例均被旁观者目击,预计增加1198例出院生存者。
  • 若未目击病例仅被识别而未实施干预,预计增加912例出院生存者。
  • 作者认为,改善识别的方法(如生物传感器技术)可能实质性改善整体生存。

适用人群与场景

  • 不列颠哥伦比亚心脏骤停登记(2019-2020年)中经急救医疗服务评估的院外心脏骤停病例。
  • 排除急救人员目击、终末期疾病或已签署不复苏意愿的病例。

研究设计与关键结果

  • 研究类型:基于登记数据的队列研究,采用中介分析和自助法逻辑回归框架建模。
  • 纳入11,412例(6314例接受急救治疗,5098例未接受急救治疗)。
  • 出院生存:未目击病例191/8879(2.2%),旁观者目击病例429/2533(17%)。
  • 旁观者目击的总效应中,识别占84%(95%CI:72,86)。
  • 若所有未目击病例均被旁观者目击,预计增加1198例出院生存者。
  • 若未目击病例被识别但未实施干预,预计增加912例出院生存者。

证据类型、等级与局限

  • 证据类型:基于登记数据的队列研究(中介分析)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,改善识别的方法(如生物传感器技术)可能带来整体生存的实质性改善。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Biosensor technologies have been proposed as a solution to provide recognition and facilitate earlier responses to unwitnessed out-of-hospital cardiac arrest (OHCA) cases. We sought to estimate the effect of recognition on survival and modelled the potential incremental impact of increased recognition of unwitnessed cases on survival to hospital discharge, to demonstrate the potential benefit of biosensor technologies.

METHODS: We included cases from the British Columbia Cardiac Arrest Registry (2019-2020), which includes Emergency Medical Services (EMS)-assessed OHCAs. We excluded cases that would not have benefitted from early recognition (EMS-witnessed, terminal illness, or do-not-resuscitate). Using a mediation analysis, we estimated the relative benefits on survival of a witness recognizing vs. intervening in an OHCA; and estimated the expected additional number of survivors resulting from increasing recognition alone using a bootstrap logistic regression framework.

RESULTS: Of 13,655 EMS-assessed cases, 11,412 were included (6314 EMS-treated, 5098 EMS-untreated). Survival to hospital discharge was 191/8879 (2.2%) in unwitnessed cases and 429/2533 (17%) in bystander-witnessed cases. Of the total effect attributable to a bystander witness, recognition accounted for 84% (95% CI: 72, 86) of the benefit. If all previously unwitnessed cases had been bystander witnessed, we would expect 1198 additional survivors. If these cases had been recognized, but no interventions performed, we would expect 912 additional survivors.

CONCLUSION: Unwitnessed OHCA account for the majority of OHCAs, yet survival is dismal. Methods to improve recognition, such as with biosensor technologies, may lead to substantial improvements in overall survival.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Hutton J, Puyat JH, Asamoah-Boaheng M, et al. The effect of recognition on survival after out-of-hospital cardiac arrest and implications for biosensor technologies. Resuscitation. 2023. PMID: 37453691. doi:10.1016/j.resuscitation.2023.109906

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。